References
- Aagenaes O, van der Hagen CB, Refsum S. Hereditary recurrent intrahepatic cholestasis from birth. Arch Dis Child. 1968;43:646–657.
- Bull LN, Roche E, Song EJ, et al. Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q. Am J Hum Genet. 2000;67:994–999.
- Aagenaes O. Hereditary cholestasis with lymphoedema (Aagenaes syndrome, cholestasis-lymphoedema syndrome). New cases and follow-up from infancy to adult age. Scand J Gastroenterol. 1998;33:335–345.
- Carrion AF, Bhamidimarri KR. Liver transplant for cholestatic liver diseases. Clin Liver Dis. 2013;17:345–359.
- Johnson TM, Overgard EB, Cohen AE, et al. Nutrition assessment and management in advanced liver disease. Nutr Clin Pract. 2013;28:15–29.
- Warren AG, Brorson H, Borud LJ, et al. Lymphedema: a comprehensive review. Ann Plast Surg. 2007;59:464–472.
- Drivdal M, Trydal T, Hagve TA, et al. Prognosis, with evaluation of general biochemistry, of liver disease in lymphoedema cholestasis syndrome 1 (LCS1/Aagenaes syndrome). Scand J Gastroenterol. 2006;41:465–471.
- Drivdal M, Loken EB, Hagve TA, et al. Do patients with lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholestatic episodes? Clin Nutr. 2010;29:525–530.
- Rimestad AHLE, Nordbotten A. The Norwegian food composition table and the database for nutrient calculations at the Institute for Nutrition Research. Norwegian J Epidemiol. 2000;10:7–16.
- Joint WHOFAOUNUEC. Protein and amino acid requirements in human nutrition. World Health Organ Tech Rep Ser. 2007;1–265, no 935.
- Johansson L, SK. Norkost 1997. National dietary survey among men and women age 16-79 years. Report no. 2/1999 (in Norwegian). The National Council on Nutrition and Physical Activity: Oslo; 1999.
- National dietary survey among men and women age 18-70 years, 2010-2011. Norkost3 (Norwegian): The Norwegian Directorate of Health.; 2012 06/2012. Report No.: IS-2000.
- Turan S, Topcu B, Gokce I, et al. Serum alkaline phosphatase levels in healthy children and evaluation of alkaline phosphatase z-scores in different types of rickets. J Clin Res Pediatr Endocrinol. 2011;3:7–11.
- Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. Cmaj. 2005;172:367–379.
- Limdi JK, Hyde GM. Evaluation of abnormal liver function tests. Postgrad Med J. 2003;79:307–312.
- Drivdal M, Slagsvold CE, Aagenaes O, et al. Hereditary lymphedema, characteristics, and variations in 17 adult patients with lymphedema cholestasis syndrome 1/Aagenaes syndrome. Lymphat Res Biol. 2014;12:251–257.
- Rockson SG. The lymphatics and the inflammatory response: lessons learned from human lymphedema. Lymphat Res Biol. 2013;11:117–120.
- Kamath S, Lip GY. Fibrinogen: biochemistry, epidemiology and determinants. Qjm. 2003;96:711–729.
- Chen J, Zhao KN, Liu GB. Estrogen-induced cholestasis: pathogenesis and therapeuticimplications. Hepatogastroenterology. 2013;60:1289–1296.
- International Society of L. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology. 2013;46:1–11.
- Sokol RJ, Farrell MK, Heubi JE, et al. Comparison of vitamin E and 25-hydroxyvitamin D absorption during childhood cholestasis. J Pediatr. 1983;103:712–717.
- Issa S, Rotthauwe HW, Burmeister W. 25 Hydroxyvitamin D and vitamin E absorption in healthy children and children with chronic intrahepatic cholestasis. Eur J Pediatr. 1989;148:605–609.
- Livingstone MB. Assessment of food intakes: are we measuring what people eat?. Br J Biomed Sci. 1995;52:58–67.
- Livingstone MB, Black AE. Markers of the validity of reported energy intake. J Nutr. 2003;133 (Suppl 3):895S–920S.
- Petlund CF. Tidsskr nor Laegeforen [Treatment of lymphedema] [Article in Norwegian]. 1987;107:557–559.
- Iversen K, Drivdal LM, Billaud Feragen KJ, et al. Quality of life in adults with lymphedema cholestasis syndrome 1. Health Qual Life Outcomes. 2018;16:146.